Zheng Feng

Company: EMD Serono, An affiliate of Merck KGaA, Darmstadt, Germany

Job title: Director - Global Clinical Biomarkers & Companion Diagnostics; Global Development

Seminars:

Panel Discussion: Establishing Partnerships to Develop, Commercialize, & Decentralize Companion Diagnostics for Unprecedented Global Impact 11:35 am

When should partnerships be optimized to leverage approval of and access to biomarker information? Maximizing market access through strategic partnerships with key stakeholders Understanding the value of consistent decentralized testing in the management of clinical trialsRead more

day: Day 3 Track C

Panel Discussion: Considering Digital Pathology & AI/ML from a Drug Development Pipeline Perspective 1:25 pm

What are the greatest barriers to routine digital pathology clinical use? What approaches can we take to overcome them? Translational studies – leveraging digital pathology to describe populations Leveraging digital pathology to define clinical endpointsRead more

day: Day Three Track A

The Dynamic Landscape of Global Deployment of Liquid Biopsy in Enabling Precision Medicine Minimal Residual Disease (MRD) Monitoring, Early Cancer Screening, and Personalized Treatment 5:30 pm

Fast-evolving liquid biopsy technologies and matrix (ctDNA, cfRNA, etc.) Clinical utilities and applications for minimal residual disease, early detection, etc. Harmonized assays and planning across varied regional regulations for global deployment AI/ML and real-world genomics data miningRead more

day: Day Two PM